rs1555979596
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_006517.5(SLC16A2):c.359_360delCT(p.Ser120CysfsTer46) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_006517.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- Allan-Herndon-Dudley syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC16A2 | NM_006517.5 | c.359_360delCT | p.Ser120CysfsTer46 | frameshift_variant | Exon 1 of 6 | ENST00000587091.6 | NP_006508.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC16A2 | ENST00000587091.6 | c.359_360delCT | p.Ser120CysfsTer46 | frameshift_variant | Exon 1 of 6 | 1 | NM_006517.5 | ENSP00000465734.1 | ||
| SLC16A2 | ENST00000636771.1 | n.104_105delCT | non_coding_transcript_exon_variant | Exon 1 of 7 | 5 | ENSP00000490445.1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Spastic paraplegia Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in SLC16A2 are known to be pathogenic (PMID: 20083155, 25527620). This variant has not been reported in the literature in individuals with SLC16A2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ser120Cysfs*46) in the SLC16A2 gene. It is expected to result in an absent or disrupted protein product. -
Inborn genetic diseases Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at